Many of the introduced cephalosporins have a common structural figure. They have a 7β-[(Z)-2-(2-aminothiazole-4-yl)-2-alkoxyiminoacetamido] side chain at C-7' position and have monocyclic or bicyclic nitrogen-containing heterocycles at C-3' position.
Recently, C-3' quaternary ammonium cephalosporins such as cepirome (CPR), 1 ceftazidime (CAZ) and cefepime (CEPM) 2 have shown increased activities against both Grampositive bacteria and Gram-negative bacteria including Psudomonas aeruginosa. 3 Therefore our efforts have been focused on synthesizing C-3' quaternary ammonium cephalosporins with more enhanced antibacterial activities and better pharmacokinetic profiles than "third-generation" antibacterial agents.
We are interested in substitution at the C-3' position with nitrogen-containing heterocyclic compounds, 1,8-naphthyridine 2, so we have prepared 1,8-naphthyridine derivatives and a new series of quaternized cephalosporins. In this paper, we wish to describe the synthesis and antibacterial activity of the novel series of cephalosporins having 1,8-naphthyridine moiety at C-3' side chain.
2,3-Disubstituted 1,8-naphthyridine derivatives, 2a-2h, were prepared either directly by Friedländer reactions, 2-aminonicotinaldehyde with α-methylene compounds using piperidine as catalyst, [4] [5] [6] or by subsequent reactions of the bicyclic products.
The quaternary ammonium cephalosporins, 7β-
carboxylic acid inner salt, 3a-3h, were prepared according to the general method as shown in Scheme 1.
7, 8 The silylation of cefotaxime (CTX) 1 was carried out with N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) in methylene chloride followed by in situ formation of the C-3' iodide with trimethylsilyl iodide (TMSI). The silylated iodo compounds were quaternized with 1,8-naphthyridine 2, to give products.
The final products, 3a-3h, were purified by column chromatography using 75% aqueous acetonitrile solution.
The in vitro antibacterial activities (MIC, µg/mL) of the new cephalosporins, 3a-3h, which are against Gram-positive and Gram-negative bacteria were determined by the Mueller-Hinton-agar dilution method.
9, 10 The results of MIC test are summarized in Table 1 and it includes those of ceftazidime and cefotaxime for comparison, as well.
Most of the compounds, 3a-3h, were superior to ceftazidime and comparable to cefotaxime in antibacterial activity against selected Gram-positive bacteria and Gram-negative bacteria. However, They were less active than ceftazidime against Pseudomonas aeruginosa ATCC 15692 and Pseudomonas aeruginosa ATCC 27853.
Especially the product 3a possessing 2-amino-1,8-naphthyridine-3-carboxylic acid group showed the best activity against Gram-positive and Gram-negative bacteria and its activity was equal to cefotaxime.
In conclusion, 7β-[(Z)-2-(2-aminothiazole-4-yl)-2-methoxyiminoacetamido]-3-[8-(2,3-disubsitituted)-1,8-naphthyridiniummethyl]-3-cephem-4-carboxylic acid inner salt, 3a-3h, showed a well-balanced antibacterial spectrum and potent activities against Gram-positive and Gram-negative bacteria. Further studies in this series will be focused on modifying their structure with a broad spectrum of antibacterial activities. The precipitated solids were collected by filteration to provide a solid product. Water (10 mL) was added to the solid, and the mixture was neutralized with saturated sodium bicarbonate solution and then concentrated. The residue was purified by column chromatography (eluent : CH3CN/H2O = 4/1) over silica gel to give 3a in 43% yield. 
